Favorable outcome of triploid neuroblastomas: a contribution to the special oncogenesis of neuroblastoma

Cancer Genetics and Cytogenetics

Volumn 167, Issue 1, 2006, Pages 51-56

  Spitz, Ruediger ^a,b   Betts, David R ^c   Simon, Thorsten ^a   Boensch, Marc ^a,b   Oestreich, Joern ^a   Niggli, Felix K ^c   Ernestus, Karen ^a   Berthold, Frank ^a,b   Hero, Barbara ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CHILD; CHROMOSOME 1; CHROMOSOME ANALYSIS; CHROMOSOME MARKER; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GROUPS BY AGE; HUMAN; HUMAN TISSUE; INFANT; KARYOTYPING; MULTIVARIATE ANALYSIS; NEUROBLASTOMA; NEWBORN; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; STRUCTURAL CHROMOSOME ABERRATION; TRIPLOIDY;

AGE OF ONSET; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 11; COHORT STUDIES; DISEASE-FREE SURVIVAL; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; KARYOTYPING; MODELS, BIOLOGICAL; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEUROBLASTOMA; PROGNOSIS; TREATMENT OUTCOME; TRISOMY;

EID: 33646186492     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2005.09.001     Document Type: Article

References (24)

1. Kaneko Y., Kanda N., Maseki N., Sakurai M., Shimamura K., and Takayama S. Different karyotypic patterns in early and advanced stage neuroblastomas. Cancer Res 47 (1987) 311-318
2. Kaneko Y., Kanda N., Maseki N., Nakachi K., Takeda T., Okabe I., and Sakurai M. Current urinary mass screening for catecholamine metabolites at 6 months of age may be detecting only a small portion of high-risk neuroblastomas: a chromosome and N-myc amplification study. J Clin Oncol 8 (1990) 2005-2013
3. Look A.T., Hayes F.A., Nitschke R., McWilliams N.B., and Green A.A. Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. N Engl J Med 311 (1984) 231-235
4. Look A.T., Hayes F.A., Shuster J.J., Douglass E.C., Castleberry R.P., Bowman L.C., Smith E.I., and Brodeur G.M. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol 9 (1991) 581-591
5. Massara F.M., Tonello M., Forni M., Fruttero A., Lantermo R., Pugno F., Corsero di Montezemolo L., and Rua S. Prognostic factors in neuroblastoma. [Usefulness of DNA analysis using flow cytometry on paraffin-embedded material.]. Pediatr Med Chir 18 (1996) 141-148
6. Bourhis J., Benard J., De Vathaire F., Wilson G.D., Hartmann O., Terrier-Lacombe M.J., Bccon-Gibod L., Lemerle J., and Riou G. Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma. Cancer Res 51 (1991) 33-36
7. Cohn S.L., Rademaker A.W., Salwen H.R., Franklin W.A., Gonzales-Crussi F., Rosen S.T., and Bauer K.D. Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma. Am J Pathol 136 (1990) 1043-1052
8. Ladenstein R., Ambros I.M., Potschger U., Amann G., Urban C., Fink F.M., Schmitt K., Ones R., Slociak M., Schilling F., Ritter J., Berthold F., Gadner H., and Ambros P.F. Prognostic significance of DNA di-tetraploidy in neuroblastoma. Med Pediatr Oncol 36 (2001) 83-92
9. Betts D.R., Koesters R., Pluss H.J., and Niggli F.K. Routine karyotyping in Wilms tumor. Cancer Genet Cytogenet 96 (1997) 151-156
10. Spitz R., Hero B., Westermann F., Ernestus K., Schwab M., and Berthold F. Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations. Genes Chromosomes Cancer 34 (2002) 299-305
11. Spitz R., Hero B., Ernestus K., and Berthold F. Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4S neuroblastoma. Clin Cancer Res 9 (2003) 52-58
12. Kusafuka T., Fukuzawa M., Oue T., Yoneda A., Okada A., and Satani M. DNA flow cytometric analysis of neuroblastoma: distinction of tetraploidy subset. J Pediatr Surg 29 (1994) 543-547
13. Kaneko Y., and Knudson A.G. Mechanism and relevance of ploidy in neuroblastoma. Genes Chromosomes Cancer 29 (2000) 89-95
14. Christiansen H., and Lampert F. Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma. Br J Cancer 57 (1988) 121-126
15. Oppedal B.R., Storm-Mathisen I., Lie S.O., and Brandtzaeg P. Prognostic factors in neuroblastoma. Clinical, histopathologic, and immunohistochemical features and DNA ploidy in relation to prognosis. Cancer 62 (1988) 772-780
16. Brodeur G.M., Seeger R.C., Schwab M., Varmus H.E., and Bishop J.M. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224 (1984) 1121-1124
17. Maris J.M., White P.S., Beltinger C.P., Sulman E.P., Castleberry R.P., Shuster J.J., Look A.T., and Brodeur G.M. Significance of chromosome 1p loss of heterozygosity in neuroblastoma. Cancer Res 15 (1995) 4664-4669
18. Guo C., White P.S., Weiss M.J., Hogarty M.D., Thompson P.M., Stram D.O., Gerbing R., Matthay K.K., Seeger R.C., Brodeur G.M., and Maris J.M. Allelic deletion at 11q23 is common in MYCN single copy neuroblastoma. Oncogene 18 (1999) 4948-4957
19. Katzenstein H.M., Bowman L.C., Brodeur G.M., Thorner P.S., Joshi V.V., Smith E.I., Look A.T., Rowe S.T., Nash M.B., Holbrook T., Alvarado C., Rao P.V., Castleberry R.P., and Cohn S.L. Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience - a pediatric oncology group study. J Clin Oncol 16 (1998) 2007-2017
20. Bowman L.C., Castleberry R.P., Cantor A., Joshi V., Cohn S.L., Smith E.I., Yu A., Brodeur G.M., Hayes F.A., and Look A.T. Genetic staging of unresectable or metastatic neuroblastoma in infants: a pediatric oncology group study. J Natl Cancer Inst 89 (1997) 373-380
21. Westermann F., and Schwab M. Genetic parameters of neuroblastomas. Cancer Lett 184 (2002) 127-147
22. Brinkley B.R. Managing the centrosome numbers game: from chaos to stability in cancer cell division. Trends Cell Biol 11 (2001) 18-21
23. Ambros I.M., Zellner A., Roald B., Amann G., Ladenstein R., Printz D., Gadner H., and Ambros P.F. Role of ploidy, chromosome 1p, and Schwann cells in the maturation of neuroblastoma. N Engl J Med 334 (1996) 1505-1511
24. Schilling F.H., Spix C., Berthold F., Erttmann R., Fehse N., Hero B., Klein G., Sander J., Schwarz K., Treuner J., Zorn U., and Michaelis J. Neuroblastoma screening at one year of age. N Engl J Med 346 (2002) 1047-1053